I wondered what was behind today's wee rise
"Glaukos get a competitive win
Glaukos stock soared more than 40% following a competitor's decision to take one of its rival products off the market. Novartis (NYSE: NVS) said that it would stop selling its CyPass Micro-Stent, which medical professionals had been using to during surgical procedures to help patients with a form of glaucoma. The problem was that the Novartis device wasn't having the results that the company had anticipated. That's bad news for Novartis, but for Glaukos, it means that more surgeons are likely to turn to its iStent Micro-Bypass product as an alternative, and investors anticipate a substantial uptick in revenue for the competing company as a result."
https://au.finance.yahoo.com/news/why-square-glaukos-ballard-power-203000462.html
Ann: Ellex on recent MIGS device withdrawl, page-4
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.81M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $65.86K | 326.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4615 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 10907 | 2 |
View Market Depth
| Last trade - 15.58pm 05/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |